Finder's Pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
TC BioPharm is a biotechnology business based in the US. TC BioPharm stocks (TCBP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.87 – a decrease of 22.32% over the previous week. TC BioPharm employs 0 staff and has a trailing 12-month revenue of around $2 million.
Finder's Pick for
Beginners
Finder's Pick for
Free Trades
Finder's Pick for
Commodity Stocks
Finder's Pick for
Global Trading
Latest market close | $0.87 |
---|---|
52-week range | $0.00 - $4.25 |
50-day moving average | $1.26 |
200-day moving average | $1.27 |
Wall St. target price | $5.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.87 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $0.87 from 2022-05-26
1 week (2022-05-20) | -22.32% |
---|---|
1 month (2022-04-28) | -37.41% |
3 months (2022-02-28) | -12.56% |
6 months (2021-11-24) | N/A |
1 year (2021-05-24) | N/A |
---|---|
2 years (2020-05-24) | N/A |
3 years (2019-05-24) | N/A |
5 years (2017-05-24) | N/A |
Revenue TTM | $2 million |
---|---|
Gross profit TTM | $2 million |
Return on assets TTM | -59.57% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | $31.4 million |
TTM: trailing 12 months
We're not expecting TC BioPharm to pay a dividend over the next 12 months.
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. .
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
Read more…Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
Read more…Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.
Read more…Steps to owning and managing BGXX stock, with 24-hour and historical pricing before you buy.
Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing Hanover Bancorp stocks, with 24-hour and historical pricing before you buy.
Everything we know about the PrimeBlock IPO, plus information on how to buy in.